Should You Give Blood Every Month On TRT?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 42-year-old man says his clinic requires blood donation every one to two months to continue testosterone, and Dr. O’Connor explains androgen-induced erythrocytosis, uncertainty around risk thresholds, and the danger of progressive iron depletion.

Video Summary

A 42-year-old man on TRT asks about mandatory monthly blood donation to keep receiving testosterone. Dr. O’Connor explains that testosterone commonly increases red blood cell production, but the exact hematocrit level at which risk becomes clinically dangerous remains uncertain.

His greater concern is that repeated phlebotomy every month or two may progressively deplete iron stores and become unsustainable. He emphasizes that androgen-induced erythrocytosis should be evaluated in the context of the individual’s complete health profile rather than managed automatically with repeated blood removal.

Dr. O’Connor recommends reviewing the member’s full ABCDs™, particularly iron status and other cardiovascular risk factors, before deciding how the elevated red blood cell measurements should be managed.

Drug Callouts

Testosterone

Testosterone is the androgen responsible for the member’s increased red blood cell production. Dr. O’Connor explains that erythrocytosis is common with androgen exposure but should not automatically trigger repeated phlebotomy without considering iron status and the individual’s broader risk profile.

Condition Callouts

Androgen-Induced Erythrocytosis

Androgen-induced erythrocytosis is the central condition in this discussion and refers to increased red blood cell concentration associated with testosterone exposure. Dr. O’Connor emphasizes that the precise level at which this becomes dangerous is uncertain and that management should account for the man’s complete cardiovascular and hematologic risk profile.

Iron Depletion

Repeated blood donation every month or two can progressively reduce iron stores in a man on testosterone. Dr. O’Connor considers this a major concern because ongoing phlebotomy may create an unsustainable cycle of treating testosterone-related erythrocytosis while producing iron depletion.

Key Takeaways

Testosterone commonly increases red blood cell production, but the exact hematocrit level at which risk becomes dangerous remains uncertain.
Repeated phlebotomy every month or two can progressively deplete iron stores and may not be sustainable long term.
Androgen-induced erythrocytosis should be evaluated using the individual’s complete risk profile rather than managed automatically from one laboratory threshold.
Dr. O’Connor recommends reviewing the full ABCDs™, especially iron status, before deciding how testosterone-related erythrocytosis should be managed.